BN Business News
Add your company to Business Communicator →

BUSINESS NEWS

Search Business News

Find articles by title or summary.

6/15/2021

USDA Revises Lentil Inspection Guidelines

The US Department of Agriculture's Agricultural Marketing Service is revising the interpretation of the special grade 'Green' in the US Standards for Lentils, in response to industry requests to redefine the definition and include criteria for mottled lentils.

6/15/2021

USDA Revises Interpretation of Whole Peas in Split Peas Standards

The US Department of Agriculture's Agricultural Marketing Service is revising the method of interpretation for determining whole peas in the Pea and Lentil Inspection Handbook, in response to requests from the pea processing industry to increase the tolerance for whole peas.

6/15/2021

USAID Seeks OMB Approval for Information Collection, Requests Public Comment

The U.S. Agency for International Development (USAID) is seeking Office of Management and Budget (OMB) approval for a proposed information collection, requesting public comment on its necessity and burden, with a 30-day extension of the initial 60-day comment period that began on March 5, 2021.

6/15/2021

Federal Travel Regulation; Taxes on Relocation Expenses, Withholding Tax Allowance (WTA) and Relocation Income Tax Allowance (RITA) Eligibility

The General Services Administration (GSA) is proposing to amend the Federal Travel Regulation to allow Withholding Tax Allowance (WTA) and Relocation Income Tax Allowance (RITA) to individuals receiving relocation allowances paid by the Federal Government, in line with changes to GSA's tax authority enacted in the National Defense Authorization Act for Fiscal Year 2020.

6/15/2021

USITC Cancels Hearing for Final Phase of Wind Tower Investigations

The USITC has cancelled a hearing for the final phase of investigations into countervailing duty and anti-dumping duties on utility scale wind towers imported from India, Malaysia, and Spain. The decision affects companies such as Vestas, Siemens Gamesa, and GE Renewable Energy, which manufacture wind turbines.

6/15/2021

FDA Corrects Notice on Withdrawal of 12 Abbreviated New Drug Applications, Including Error in Lederle Laboratories' Nystatin Ointment Approval

The Food and Drug Administration (FDA) is correcting a notice regarding the withdrawal of approval of 12 abbreviated new drug applications (ANDAs), including a mistake in the application number for Lederle Laboratories' Nystatin Ointment. The FDA previously withdrew the approval of these ANDAs as of June 11, 2021, but the error was discovered in a May 12, 2021, notice in the Federal Register.

6/15/2021

Proposed Information Collections; Comment Request (No. 82)

The Office of Information and Regulatory Affairs is seeking public comments on proposed information collections, as mandated by the Paperwork Reduction Act of 1995, with the goal of reducing paperwork and respondent burden.

6/15/2021

FEMA Declares Major Disaster for Alabama

The Federal Emergency Management Agency (FEMA) has issued a public assistance declaration for the state of Alabama following a severe storm, straight-line winds, and tornadoes that occurred from March 25 to 26, 2021.

6/14/2021

DEA Schedules N-Ethylpentylone as Schedule I Controlled Substance

The Drug Enforcement Administration has permanently placed 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one, also known as N-ethylpentylone or ephylone, in Schedule I of the Controlled Substances Act, imposing strict regulatory controls and penalties on those who handle or manufacture the substance.

6/11/2021

Inviting Applications for Rural Cooperative Development Grants

The Rural Business-Cooperative Service is accepting $5.8 million in FY 2021 funding for the Rural Cooperative Development Grant program, which aims to improve rural economic conditions through cooperative development, targeting non-profit corporations and institutions of higher education.

6/11/2021

USAID Revises Claims Collection Regulation to Comply with DATA Act

The U.S. Agency for International Development is updating its claims collection policy to align with the Digital Accountability and Transparency Act of 2014, requiring the referral of over 120-day delinquent, non-tax debt to the Secretary of the Treasury, with the goal of improving claim collection efficiency.

6/11/2021

FDA Revises Regulatory Review Period for BRAVECTO Animal Drug

The US Food and Drug Administration (FDA) has revised the regulatory review period for the animal drug BRAVECTO after reconsideration from the applicant. The FDA published the revised review period in a notice in the Federal Register on February 12, 2018.